KAS
IBB icon

Kestra Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

Kestra Advisory Services’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.98M Sell
47,195
-266
-0.6% -$45.7K 0.03% 553
2026
Q1 		$8.01M Buy
47,461
+5,155
+12% +$881K 0.03% 551
2025
Q4 		$7.14M Buy
42,306
+3,054
+8% +$496K 0.03% 553
2025
Q3 		$5.67M Sell
39,252
-2,756
-7% -$376K 0.03% 623
2025
Q2 		$5.31M Buy
42,008
+3,831
+10% +$470K 0.03% 608
2025
Q1 		$4.88M Buy
38,177
+703
+2% +$95.3K 0.02% 582
2024
Q4 		$4.95M Sell
37,474
-4,730
-11% -$665K 0.03% 583
2024
Q3 		$6.14M Sell
42,204
-3,061
-7% -$443K 0.03% 527
2024
Q2 		$6.02M Buy
45,265
+7,586
+20% +$1.01M 0.03% 529
2024
Q1 		$5.17M Sell
37,679
-260
-0.7% -$35.5K 0.03% 507
2023
Q4 		$5.15M Sell
37,939
-1,690
-4% -$206K 0.04% 438
2023
Q3 		$4.85M Buy
39,629
+234
+0.6% +$29.8K 0.05% 400
2023
Q2 		$5M Sell
39,395
-4,991
-11% -$648K 0.05% 372
2023
Q1 		$5.73M Sell
44,386
-16,093
-27% -$2.11M 0.06% 313
2022
Q4 		$7.94M Buy
60,479
+10,990
+22% +$1.42M 0.07% 300
2022
Q3 		$5.79M Sell
49,489
-949
-2% -$118K 0.06% 337
2022
Q2 		$5.93M Buy
50,438
+315
+0.6% +$37.4K 0.06% 322
2022
Q1 		$6.53M Buy
50,123
+596
+1% +$77.6K 0.07% 308
2021
Q4 		$7.56M Sell
49,527
-8,715
-15% -$1.35M 0.08% 274
2021
Q3 		$9.42M Buy
58,242
+6,726
+13% +$1.13M 0.09% 235
2021
Q2 		$8.43M Buy
51,516
+362
+0.7% +$55.8K 0.1% 231
2021
Q1 		$7.7M Sell
51,154
-17,112
-25% -$2.72M 0.1% 240
2020
Q4 		$10.4M Buy
68,266
+17,991
+36% +$2.57M 0.12% 198
2020
Q3 		$6.81M Buy
+50,275
New +$6.82M 0.13% 192

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Kestra Advisory Services's IBB Position: Q2 2026 in Review

Kestra Advisory Services reduced its iShares Biotechnology ETF (IBB) stake by 0.56% in Q2 2026, selling an estimated $45.7K and leaving 47,195 shares worth $8.98M. The position accounts for 0.03% of the portfolio, ranked #553.

Kestra Advisory Services first reported a position in IBB in Q3 2020 and has held it in 24 quarters since. The position peaked at $10.4M in Q4 2020. 958 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Kestra Advisory Services held 47,195 shares of iShares Biotechnology ETF worth $8.98M as of Q2 2026.
  • Kestra Advisory Services sold 266 iShares Biotechnology ETF shares in Q2 2026, an estimated $45.7K.
  • iShares Biotechnology ETF made up 0.03% of Kestra Advisory Services's portfolio in Q2 2026, its #553 holding.
  • Kestra Advisory Services first reported a position in iShares Biotechnology ETF in Q3 2020 and has held it in 24 quarters since.
  • Kestra Advisory Services's iShares Biotechnology ETF position peaked at $10.4M in Q4 2020.
  • 958 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.